The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

δ-Valerolactone-Global Market Insights and Sales Trends 2024

δ-Valerolactone-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1880156

No of Pages : 98

Synopsis
The global δ-Valerolactone market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of δ-Valerolactone in various end use industries. The expanding demands from the Coatings, Adhesives, Resin Additives and Pharmaceutical and Agrochemical Intermediates, are propelling δ-Valerolactone market. Assay: 98%, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Assay: 99% segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for δ-Valerolactone market, driven by demand from China, the second largest economy with some signs of stabilising, the δ-Valerolactone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for δ-Valerolactone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global δ-Valerolactone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global δ-Valerolactone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, δ-Valerolactone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of δ-Valerolactone covered in this report include BASF, Ube Industries, MYJ Chemical, Ningbo INNO Pharmchem, Skylead Pharmaceuticals & Chemicals, Penta Manufacturing and Zhejiang Boadge Chemical, etc.
The global δ-Valerolactone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BASF
Ube Industries
MYJ Chemical
Ningbo INNO Pharmchem
Skylead Pharmaceuticals & Chemicals
Penta Manufacturing
Zhejiang Boadge Chemical
Global δ-Valerolactone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global δ-Valerolactone market, Segment by Type:
Assay: 98%
Assay: 99%
Global δ-Valerolactone market, by Application
Coatings, Adhesives, Resin Additives
Pharmaceutical and Agrochemical Intermediates
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of δ-Valerolactone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of δ-Valerolactone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 δ-Valerolactone Market Overview
1.1 δ-Valerolactone Product Overview
1.2 δ-Valerolactone Market Segment by Type
1.2.1 Assay: 98%
1.2.2 Assay: 99%
1.3 Global δ-Valerolactone Market Size by Type
1.3.1 Global δ-Valerolactone Market Size Overview by Type (2018-2029)
1.3.2 Global δ-Valerolactone Historic Market Size Review by Type (2018-2023)
1.3.3 Global δ-Valerolactone Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America δ-Valerolactone Sales Breakdown by Type (2018-2023)
1.4.2 Europe δ-Valerolactone Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific δ-Valerolactone Sales Breakdown by Type (2018-2023)
1.4.4 Latin America δ-Valerolactone Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa δ-Valerolactone Sales Breakdown by Type (2018-2023)
2 Global δ-Valerolactone Market Competition by Company
2.1 Global Top Players by δ-Valerolactone Sales (2018-2023)
2.2 Global Top Players by δ-Valerolactone Revenue (2018-2023)
2.3 Global Top Players by δ-Valerolactone Price (2018-2023)
2.4 Global Top Manufacturers δ-Valerolactone Manufacturing Base Distribution, Sales Area, Product Type
2.5 δ-Valerolactone Market Competitive Situation and Trends
2.5.1 δ-Valerolactone Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by δ-Valerolactone Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in δ-Valerolactone as of 2022)
2.7 Date of Key Manufacturers Enter into δ-Valerolactone Market
2.8 Key Manufacturers δ-Valerolactone Product Offered
2.9 Mergers & Acquisitions, Expansion
3 δ-Valerolactone Status and Outlook by Region
3.1 Global δ-Valerolactone Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global δ-Valerolactone Historic Market Size by Region
3.2.1 Global δ-Valerolactone Sales in Volume by Region (2018-2023)
3.2.2 Global δ-Valerolactone Sales in Value by Region (2018-2023)
3.2.3 Global δ-Valerolactone Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global δ-Valerolactone Forecasted Market Size by Region
3.3.1 Global δ-Valerolactone Sales in Volume by Region (2024-2029)
3.3.2 Global δ-Valerolactone Sales in Value by Region (2024-2029)
3.3.3 Global δ-Valerolactone Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global δ-Valerolactone by Application
4.1 δ-Valerolactone Market Segment by Application
4.1.1 Coatings, Adhesives, Resin Additives
4.1.2 Pharmaceutical and Agrochemical Intermediates
4.2 Global δ-Valerolactone Market Size by Application
4.2.1 Global δ-Valerolactone Market Size Overview by Application (2018-2029)
4.2.2 Global δ-Valerolactone Historic Market Size Review by Application (2018-2023)
4.2.3 Global δ-Valerolactone Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America δ-Valerolactone Sales Breakdown by Application (2018-2023)
4.3.2 Europe δ-Valerolactone Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific δ-Valerolactone Sales Breakdown by Application (2018-2023)
4.3.4 Latin America δ-Valerolactone Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa δ-Valerolactone Sales Breakdown by Application (2018-2023)
5 North America δ-Valerolactone by Country
5.1 North America δ-Valerolactone Historic Market Size by Country
5.1.1 North America δ-Valerolactone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America δ-Valerolactone Sales in Volume by Country (2018-2023)
5.1.3 North America δ-Valerolactone Sales in Value by Country (2018-2023)
5.2 North America δ-Valerolactone Forecasted Market Size by Country
5.2.1 North America δ-Valerolactone Sales in Volume by Country (2024-2029)
5.2.2 North America δ-Valerolactone Sales in Value by Country (2024-2029)
6 Europe δ-Valerolactone by Country
6.1 Europe δ-Valerolactone Historic Market Size by Country
6.1.1 Europe δ-Valerolactone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe δ-Valerolactone Sales in Volume by Country (2018-2023)
6.1.3 Europe δ-Valerolactone Sales in Value by Country (2018-2023)
6.2 Europe δ-Valerolactone Forecasted Market Size by Country
6.2.1 Europe δ-Valerolactone Sales in Volume by Country (2024-2029)
6.2.2 Europe δ-Valerolactone Sales in Value by Country (2024-2029)
7 Asia-Pacific δ-Valerolactone by Region
7.1 Asia-Pacific δ-Valerolactone Historic Market Size by Region
7.1.1 Asia-Pacific δ-Valerolactone Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific δ-Valerolactone Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific δ-Valerolactone Sales in Value by Region (2018-2023)
7.2 Asia-Pacific δ-Valerolactone Forecasted Market Size by Region
7.2.1 Asia-Pacific δ-Valerolactone Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific δ-Valerolactone Sales in Value by Region (2024-2029)
8 Latin America δ-Valerolactone by Country
8.1 Latin America δ-Valerolactone Historic Market Size by Country
8.1.1 Latin America δ-Valerolactone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America δ-Valerolactone Sales in Volume by Country (2018-2023)
8.1.3 Latin America δ-Valerolactone Sales in Value by Country (2018-2023)
8.2 Latin America δ-Valerolactone Forecasted Market Size by Country
8.2.1 Latin America δ-Valerolactone Sales in Volume by Country (2024-2029)
8.2.2 Latin America δ-Valerolactone Sales in Value by Country (2024-2029)
9 Middle East and Africa δ-Valerolactone by Country
9.1 Middle East and Africa δ-Valerolactone Historic Market Size by Country
9.1.1 Middle East and Africa δ-Valerolactone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa δ-Valerolactone Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa δ-Valerolactone Sales in Value by Country (2018-2023)
9.2 Middle East and Africa δ-Valerolactone Forecasted Market Size by Country
9.2.1 Middle East and Africa δ-Valerolactone Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa δ-Valerolactone Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 BASF
10.1.1 BASF Company Information
10.1.2 BASF Introduction and Business Overview
10.1.3 BASF δ-Valerolactone Sales, Revenue and Gross Margin (2018-2023)
10.1.4 BASF δ-Valerolactone Products Offered
10.1.5 BASF Recent Development
10.2 Ube Industries
10.2.1 Ube Industries Company Information
10.2.2 Ube Industries Introduction and Business Overview
10.2.3 Ube Industries δ-Valerolactone Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Ube Industries δ-Valerolactone Products Offered
10.2.5 Ube Industries Recent Development
10.3 MYJ Chemical
10.3.1 MYJ Chemical Company Information
10.3.2 MYJ Chemical Introduction and Business Overview
10.3.3 MYJ Chemical δ-Valerolactone Sales, Revenue and Gross Margin (2018-2023)
10.3.4 MYJ Chemical δ-Valerolactone Products Offered
10.3.5 MYJ Chemical Recent Development
10.4 Ningbo INNO Pharmchem
10.4.1 Ningbo INNO Pharmchem Company Information
10.4.2 Ningbo INNO Pharmchem Introduction and Business Overview
10.4.3 Ningbo INNO Pharmchem δ-Valerolactone Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Ningbo INNO Pharmchem δ-Valerolactone Products Offered
10.4.5 Ningbo INNO Pharmchem Recent Development
10.5 Skylead Pharmaceuticals & Chemicals
10.5.1 Skylead Pharmaceuticals & Chemicals Company Information
10.5.2 Skylead Pharmaceuticals & Chemicals Introduction and Business Overview
10.5.3 Skylead Pharmaceuticals & Chemicals δ-Valerolactone Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Skylead Pharmaceuticals & Chemicals δ-Valerolactone Products Offered
10.5.5 Skylead Pharmaceuticals & Chemicals Recent Development
10.6 Penta Manufacturing
10.6.1 Penta Manufacturing Company Information
10.6.2 Penta Manufacturing Introduction and Business Overview
10.6.3 Penta Manufacturing δ-Valerolactone Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Penta Manufacturing δ-Valerolactone Products Offered
10.6.5 Penta Manufacturing Recent Development
10.7 Zhejiang Boadge Chemical
10.7.1 Zhejiang Boadge Chemical Company Information
10.7.2 Zhejiang Boadge Chemical Introduction and Business Overview
10.7.3 Zhejiang Boadge Chemical δ-Valerolactone Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Zhejiang Boadge Chemical δ-Valerolactone Products Offered
10.7.5 Zhejiang Boadge Chemical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 δ-Valerolactone Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 δ-Valerolactone Industrial Chain Analysis
11.4 δ-Valerolactone Market Dynamics
11.4.1 δ-Valerolactone Industry Trends
11.4.2 δ-Valerolactone Market Drivers
11.4.3 δ-Valerolactone Market Challenges
11.4.4 δ-Valerolactone Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 δ-Valerolactone Distributors
12.3 δ-Valerolactone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’